President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.
JoNel Aleccia
JoNel is a national reporter covering food and nutrition for The Associated Press.
